期刊文献+

嗜铬细胞瘤患者VHL基因突变的分析 被引量:5

Genetic detection and analysis of the VHL gene in patients with sporadic pheochromocytoma
原文传递
导出
摘要 目的探讨散发性嗜铬细胞瘤患者VHL基因突变检测及其意义。方法从41例散发性嗜铬细胞瘤患者的外周血及嗜铬细胞瘤组织中提取基因组DNA,进行VHL基因测序分析,存在基因突变者再进行家系成员筛查。以50例健康志愿者外周血提取的DNA样本作为对照。结果3例散发性嗜铬细胞瘤患者的VHL基因第2外显子存在基因突变,其中1例为572位核苷酸由G突变为C,该突变导致120位编码氨基酸由精氨酸转变为苏氨酸;2例为623位核苷酸处插入一重复核苷酸T(TTTGTtG),导致下游读码框移位。其余38例患者和50例健康志愿者未发现VHL基因突变。进一步对3例发生基因突变患者的家系成员进行筛查,分别筛查出3例G572C携带者、3例623(TTTGTtG)携带者。结论散发性嗜铬细胞瘤患者中存在可能致病的VHL基因突变,建议对散发性嗜铬细胞瘤患者进行VHL基因检测分析。VHL基因检测有望作为临床遗传性嗜铬细胞瘤基因诊断的指标之一。 Objective To carry out a genetic detection and analysis of Von Hippel-Lindau (VHL) gene in Chinese patients with sporadic pheochromocytoma. Methods DNA samples were extracted from peripheral blood cells and fresh pheochromocytoma specimens from 41 patients with sporadic pheochromocytoma were assayed by polymerase chain reaction and direct sequencing. The DNA samples of 50 healthy volunteers were extracted from peripheral blood as a control. The PCR products of exon 1, exon 2 and exon 3 were used for molecular analysis of the VHL gene. The genetic detection of family members of VHL gene mutations was also performed. Results One of mutations was located at nucleotide 572 (G→C) in exon 2, presenting a codon 120 from arginine (R) to threonine (T). Tow small insertions were locatated at nucleotide 623T (TTTGTtG) in exon 2, leading to a frameshift mutation. There were also three carriers of G572C and three carriers of 623T (TTTGTtG) in family members of the three cases. Conclusion There are some Chinese patients with sporadic pheochromocytoma with tumorigenic VHL gene mutations. It is recommended to use the genetic detection and analysis of VHL gene as a routine examination for patients with sporadic pheoehromoeytoma under the age of 50 years with questionable family history. The genetic detection and analysis of VHL gene may be useful as a marker for the diagnosis of hereditary pheochromocytoma.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第5期361-365,共5页 Chinese Journal of Oncology
关键词 嗜铬细胞瘤 VHL基因 突变 诊断 Pheochromocytoma VHL gene Mutation Diagnosis
  • 相关文献

参考文献15

  • 1Hes FJ, Hoppener JW, Lips CJ. Clinical review 155: pheochromocytom in Von Hippel-Lindau disease. J Clin Endocrinol Metab, 2003, 88:969-974.
  • 2Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet, 2000, 26:268-270.
  • 3Baysal BE, Ferrell RE, Willett-Brozick JE. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science, 2000, 287:848-851.
  • 4Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma type 3. Nat Genet, 2000, 26:268-270.
  • 5Jime'nez C, Cote G, Arnold A, et al. Review: should patients with apparently sporadic pheochromocytomas or paragangliomas he screened for hereditary syndromes. J Clin Endocrinol Metab, 2006, 91:2851-2858.
  • 6Glavac D, Neumann HP, Wittke C, et al. Mutations in the VHL tumor suppressor gene and associated lesions in families with yon Hippel-Lindau disease from central Europe. Hum Genet, 1996, 98:271-280.
  • 7Walther MM, Reiter R, Keiser HR, et al. Clinical and genetic characterization of pheochromocytoma in yon I-Iippel-Lindau families : comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol, 1999, 162:659- 654.
  • 8Bender BU, Gutsche M, Glasker S, et al. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas. J Clin Endocrinol Metab, 2000, 85 : 4568- 4574.
  • 9Kaelin WG Jr. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer, 2002, 2:673-682.
  • 10Kondo K, Klco J, Nakamura E, et al. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell, 2002, 1:237-246.

二级参考文献11

  • 1Glavac D, Neumann HP, Wittke C, et al. Mutations in the VHL tumor suppressor gene and associated lesions in families with yon Hippel-Lindau disease from central Europe. Hum Genet, 1996,98:271-280.
  • 2Birch-Machin MA, Taylor RW, Cochran B, et al. Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex Ⅱ gene. Ann Neurol, 2000,48 : 330-335.
  • 3Amar L, Bertherat J, Baudin E, et ol. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol, 2005,23 : 8812-8818.
  • 4Walther MM, Reiter R, Keiser HR, et al. Clinical and genetic characterization of pheochromocytoma in yon Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol , 1999,162:659-664.
  • 5Ritter MM,Frilling A, Crossey PA, et al. Isolated familial pheochromocytoma as a variant of van Hippel-Lindau disease. J Clin Endocrinol Metab, 1996,81 : 1035-1037.
  • 6Sanso G, Rudaz MC, Levin G, et ol. Familial isolated pheochromocytoma presenting a new mutation in the von Hippel-Lindau gene. Am J Hypertens, 2004,17:1107-1111.
  • 7Woodward ER, Eng C, McMahon R, et ol. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL. Hum Mol Genet, 1997,6:1051-1056.
  • 8Gilcrease MZ,Schmidt L, Zbar B, et al. Somatic yon Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis. Hum Pathol, 1995,26:1341-1346.
  • 9Neumann HP, Bausch B, McWhinney SR, et ol. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med, 2002,346: 1459-1466.
  • 10张进,黄翼然,王晶钉,范晓东.中国人一个von Hippel-Lindau病的大家系调查及基因突变研究[J].中华医学遗传学杂志,2004,21(1):5-9. 被引量:17

共引文献5

同被引文献28

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部